APA (7th ed.) Citation

Ohara, M., Yokoyama, H., Seino, H., Fujikawa, T., Kohata, Y., Takahashi, N., . . . Yamagishi, S. Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: An open-label, prospective, randomized, multicenter, parallel-group comparison study. BMC.

Chicago Style (17th ed.) Citation

Ohara, Makoto, et al. Effects of Switching from Dipeptidyl Peptidase 4 Inhibitors to Oral Semaglutide on Oxidative Stress and Glycemic Variability in Patients with Type 2 Diabetes: An Open-label, Prospective, Randomized, Multicenter, Parallel-group Comparison Study. BMC.

MLA (9th ed.) Citation

Ohara, Makoto, et al. Effects of Switching from Dipeptidyl Peptidase 4 Inhibitors to Oral Semaglutide on Oxidative Stress and Glycemic Variability in Patients with Type 2 Diabetes: An Open-label, Prospective, Randomized, Multicenter, Parallel-group Comparison Study. BMC.